Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Highly stable CsPbBr3 perovskite phases from new lead β-diketonate glyme adducts

Lorenzo Sirna a, Anna Lucia Pellegrino *a, Salvatore Pio Sciacca a, Martina Lippi b, Patrizia Rossi b, Carmela Bonaccorso c, Giuseppe Bengasi d, Marina Foti d and Graziella Malandrino *a
aDipartimento Scienze Chimiche, Università degli Studi di Catania, and INSTM UdR Catania, Viale Andrea Doria 6, 95125 Catania, Italy. E-mail: annalucia.pellegrino@unict.it; graziella.malandrino@unict.it
bDipartimento di Ingegneria Industriale, Università di Firenze, Via Santa Marta 3, 50136 Firenze, Italy
cDipartimento Scienze Chimiche, Università degli Studi di Catania, Viale Andrea Doria 6, 95125 Catania, Italy
d3SUN s.r.l., Contrada Blocco Torrazze, 95121, Catania, Italy

Received 29th November 2023 , Accepted 8th February 2024

First published on 12th February 2024


Abstract

Lead is one of the key metals of the all-inorganic lead halide perovskites. This work tailors novel architectures of lead's coordination sphere using a β-diketone (H-hfa = 1,1,1,5,5,5-hexafluoro-2,4-pentanedione) and a glyme (monoglyme, diglyme, triglyme, or tetraglyme) ligand. The coordination chemistry and thermal behaviour of these “Pb(hfa)2·glyme” adducts have been analysed through FT-IR spectroscopy, 1H and 13C NMR analyses, thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). Single-crystal X-ray diffraction studies provide evidence of the formation of a monomeric Pb(hfa)2·monoglyme structure. In order to validate the potentiality of these “Pb(hfa)2·glyme” precursors for the fabrication of Pb-based halide perovskites, a facile, one-step and low-temperature solution approach has been applied to prepare CsPbBr3 microcrystals with a process carried out in air under atmospheric pressure. Pure stoichiometric CsPbBr3 powders, obtained using Cs(hfa) and Br2 as cesium and bromide sources, respectively, show excellent stability under atmospheric conditions. Better results are obtained in terms of yield and stability from the diglyme and tetraglyme lead adducts. Field emission scanning electron microscopy (FE-SEM) indicates a good uniform morphology of cubic grains, while the structure and the 1[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]3 stoichiometry of Cs[thin space (1/6-em)]:[thin space (1/6-em)]Pb[thin space (1/6-em)]:[thin space (1/6-em)]Br are confirmed by X-ray diffraction (XRD) and energy dispersive X-ray analysis (EDX), respectively. Tauc plots derived from absorption spectroscopy point to optical energy band-gaps (Eg) in the 2.21–2.27 eV range, in agreement with literature data. The present research elucidates the potential of these novel “Pb(hfa)2·glyme” adducts as promising lead precursors for CsPbBr3 perovskite synthesis, paving the way for their implementation in various technological applications.


1. Introduction

In the past few years, lead halide perovskites (LHPs), such as the hybrid organic–inorganic system of the type CH3NH3PbX3[thin space (1/6-em)]1,2 (known as MAPbX3, with MA = methylammonium cation) and HC(NH2)2PbX3[thin space (1/6-em)]3 (FAPbX3 in which FA is the formamidinium ion) or all-inorganic CsPbX3 perovskites4,5 (with X = Cl, Br, and I), have been intensively investigated.6,7 In fact, they present unique properties such as a large light absorption coefficient,8,9 fast generation of charge carriers,10 a long carrier lifetime,11 a high photoluminescence quantum yield (PLQY),12,13 and a widely tunable band-gap.14,15

For these reasons, LHPs are suitable for a wide range of optoelectronic applications,16,17 including light emitting diodes (LEDs),18–20 photodetectors,21,22 lasers,23,24 and also catalysis25,26 and solar cells.27–29 Among them, the all-inorganic lead halide perovskites have attracted a lot of attention due to the as-mentioned optoelectronic properties and their improved stability.30–33 This class of perovskites combines the benefits of having inexpensive and abundant elements with the stability of the structure because of the replacement of the organic component that is sensitive to the environment.34,35 The all-inorganic lead halide perovskites present a structure of the general formula ABX3 in which the A site is occupied by a Cs atom, the B site is occupied by an atom of Pb, and X is equal to Cl, Br, or I.36

Among them, the CsPbBr3 phase represents an excellent candidate for a wide range of emerging technological applications. Particularly, CsPbBr3 is investigated as an active material in photocatalysis37 for fundamental organic reactions such as C–C, C–N, and C–O38 bond formation and CO2 reduction.39 Furthermore, CsPbBr3 crystals can be applied as a component for solar cells,40 while nanocrystals have been used for the synthesis of a solid-state luminescent gas sensor.41

Typically, this kind of perovskite in the form of films or other structures (i.e. nanocrystals and quantum dots) is produced using solution processes.42 However, most of these approaches are based on dissolving the precursors into organic solvents such as dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF) and toluene43 or require the use of surfactant species such as oleic acid (OA) and/or oleylamine (OLA).44,45 For instance, Zhang and co-workers developed a solution-process for MAPbX3 synthesis in which a perovskite solution was prepared by dissolving a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 molar ratio of PbX2 and MAX in DMF or DMF/DMSO (1[thin space (1/6-em)]:[thin space (1/6-em)]1).46 Sun et al. reported the fabrication of a CsPbBr3 film through the solubilisation of the CsBr and PbBr2 precursors in DMSO.47 On the other hand, vapor-phase methods were also intensively investigated.48,49 A dual-source evaporation system was reported by Liu et al. to obtain a CH3NH3PbI3−xClx perovskite50 and by Huang et al. for the development of a CsPbI3 based solar cell.51 El Ajjouri and co-workers developed a single-source vacuum deposition in which CsX and PbX2 were mixed in a crucible and then perovskite thin films were deposited in a high vacuum chamber.52 However, although these methods are widely used, energetic conditions such as high temperatures or low pressures are required.

A lead ion presents a large ionic radius (Pb(II)r6-coord = 1.19 Å)53 and for this reason it is responsible for interesting coordination moieties. In fact, different lead precursors are reported in the literature, such as tetraethyl (PbEt4) and the lead triethyl alkoxide, Et3Pb(OR), where R is a tert-butyl or a neopentyl group.54,55 However, these metalorganic compounds are extremely toxic due to their high volatility, e.g. the b.p. of PbEt4 is around 80 °C and the temperature used for this precursor in the plasma enhanced chemical vapor deposition process of PbTiO3 is −11 °C,55 and this limits their possible wide applications.56

Among organic ligands, β-diketone is a mono-anion and is one of the most used ligand systems for the complexation of metal ions due to the two oxygen atoms in its structure, which offer a variety of metal–organic architectures as a bidentate ligand.57–61 Lead β-diketonates are used as precursors in vapor phase processes, such as the case of Pb(tmhd)2 [(H-tmhd = 2,2,6,6-tetramethyl-3,5-heptanedione)], Pb(acac)2, [(H-acac = 2,4-pentanedione)], and their derivatives.56,62

It has been demonstrated that glymes, through oxygen-ion complexation, are very important for the stabilization of alkaline,61,63,64 alkaline-earth65,66 and rare-earth67 metals. The presence of such a class of multidentate ligands, in fact, permits also to fine-tune the properties of the final metal adducts in terms of thermal stability, moisture- and air-sensitivity, solubility, and volatility. For instance, these compounds show good solubility in a large number of organic solvents.57

In this work we have developed novel lead precursors of the type “Pb(hfa)2·glyme” [H-hfa = 1,1,1,5,5,5-hexafluoro-2,4-pentanedione, with glyme = monoglyme (1,2-dimethoxyethane), triglyme (2,5,8,11-tetraoxadodecane) and tetraglyme (2,5,8,11,14-pentaoxapentadecane)], by changing the polyether in order to investigate how the adducts’ properties are affected by the glyme nature and in turn may influence the formation of the CsPbBr3 phase. FT-IR spectroscopy, and 1H and 13C NMR analyses have been carried out to obtain information about the coordination of lead. Single-crystal X-ray diffraction of the Pb(hfa)2·monoglyme has assessed the formation of a monomeric adduct. Thermogravimetric analyses (TGA), differential scanning calorimetry analyses (DSC), and melting point measurements have been used to investigate the thermal properties and stability of the adducts. In addition, for the sake of completeness, we also report the diglyme-based [(1-methoxy-2-(2-methoxyethoxy)ethane)] adduct, i.e. [Pb(hfa)2·diglyme]2, which had been previously reported and applied as a precursor in vapour-phase synthetic processes.56

Then, as a proof-of-concept of applications of these “Pb(hfa)2·glyme” precursors, a facile, one-step and room-temperature solution approach has been applied to prepare CsPbBr3 microcrystals. Cs(hfa) and Br2 are used as cesium and bromide sources, respectively. The effects of the different ligands on the performance of lead adducts in CsPbBr3 microcrystal formation are investigated. Structural, morphological, and compositional analyses of the final products, carried out through X-ray diffraction (XRD), field-emission scanning electron microscopy (FE-SEM), and energy dispersive X-ray analysis (EDX), respectively, are used to study the performance and the main characteristics of both the as-prepared and the six-month aged samples. Finally, the optical band gaps have been evaluated through Tauc plots starting from dispersions of CsPbBr3 microcrystals.

2. Experimental

2.1 Materials and methods

Lead oxide (PbO), bromine (Br2), and 1,1,1,5,5,5-hexafluoro-2,4-pentanedione (H-hfa, >98%), were purchased from Strem Chemicals and used without further purification. Monoglyme (1,2-dimethoxyethane, 99.5%), diglyme (bis(2-methoxyethyl)ether, 99.5%), triglyme (2,5,8,11-tetraoxadodecane, >98%), tetraglyme (2,5,8,11,14-pentaoxapentadecane, >99%), dichloromethane (CH2Cl2, >99.5%), ethanol (CH3CH2OH, 99.8%), and n-pentane (CH3(CH2)3CH3, ≥99%) were purchased from Sigma Aldrich.

2.2 General procedures

Synthesis of Pb(hfa)2·monoglyme, 1. PbO (1.712 g, 7.7 mmol) 10% excess was suspended in dichloromethane (50 mL). Then, monoglyme (0.631 g per 0.727 mL, 7 mmol) was added to the suspension under stirring. Then, after 10 min, Hhfa (2.912 g per 2.000 mL, 14 mmol) was added, and the mixture was refluxed under stirring for 2 hours. The excess of PbO was filtered off. Light-yellow crystals were collected after the evaporation of dichloromethane. The reaction yield was 83%.
Synthesis of [Pb(hfa)2·diglyme]2, 2. The precursor was synthesized using the procedure reported in ref. 56, from PbO (1.714 g, 7.7 mmol), 10% excess, suspended in dichloromethane (50 mL), diglyme (0.939 g per 0.996 mL, 7 mmol), and Hhfa (2.912 g per 2.00 mL, 14 mmol). Light-yellow crystals were collected after the evaporation of dichloromethane. The reaction yield was 89%.
Synthesis of Pb(hfa)2·triglyme·H2O, 3. The adduct was synthesized following the procedure described for 1, from PbO (1.713 g, 7.7 mmol), 10% excess, triglyme (1.248 g per 1.267 mL, 7 mmol), and Hhfa (2.912 g per 2.000 mL, 14 mmol) in dichloromethane (50 mL). The resulting compound was sticky, so it was washed with ethanol. After the evaporation of the ethanol, light yellow sticky crystals were collected. The reaction yield was 71%.
Synthesis of Pb(hfa)2·tetraglyme, 4. The adduct was synthesized following the procedure for 1 from PbO (1.714 g, 7.7 mmol), about 10% excess, suspended in dichloromethane (50 mL), tetraglyme (1.556 g per 1.542 mL, 7 mmol) and Hhfa (2.912 g per 2.000 mL, 14 mmol). Light-yellow crystals were collected after the evaporation of dichloromethane. The reaction yield was 88%.

2.3 Precursor characterization

A Jasco FT/IR-430 spectrometer was used to record Fourier transform infrared (FT-IR) spectra with nujol mulls between NaCl plates.

NMR experiments in CD3CN were carried out at 27 °C using a 500 MHz spectrometer (1H NMR at 499.88 MHz and 13C-NMR at 125.7 MHz) equipped with a pulse-field gradient module (Z-axis) and a tunable 5 mm Varian inverse detection probe (ID-PFG). Chemical shifts (δ) are reported in ppm and are referenced to a residual undertreated solvent.

A Kofler hot-stage microscope was used to measure the melting points of the precursors. Thermogravimetric analysis studies were performed using the STARe software and a Mettler Toledo TGA2. Dynamic thermal studies were carried out under purified nitrogen flow (50 sccm) under atmospheric pressure with a 5 °C min−1 heating rate. The weights of the samples were between 10 and 18 mg. Differential scanning calorimetry analyses were executed using a Mettler Toledo Star System DSC 3 calorimeter under purified nitrogen flow (30 sccm) and atmospheric pressure with a 5 °C min−1 heating rate. The weights of the samples were between 10 and 14 mg.

2.4 Single crystal X-ray structure

Single crystal X-ray diffraction data of Pb(hfa)2·monoglyme (1) were collected using a Bruker Apex-II diffractometer equipped with a CCD detector (T = 100 K; Mo-Kα radiation, λ = 0.71073 Å). For the data collection the APEX2 software was used,68 while data integration and reduction were performed using the Bruker SAINT software.69 The crystal structure was solved using the SIR-2004 package,70 and refined by full-matrix least squares against F2 using all data (SHELXL-2018/3).71 Several crystals of Pb(hfa)2·monoglyme were tested and the data reported in the present article are those obtained for the best single crystal we were able to find. The chosen crystal was very small in order to avoid absorption problems. All the non-hydrogen atoms, with the exception of those belonging to disordered moieties (see below), were refined with anisotropic displacement parameters, while the hydrogen atoms were placed in a calculated position and their thermal parameter was set in accordance with that of the atoms to which they were bonded. All the fluorine atoms, with the exception of the three bonded to C5A (see Fig. S1), were in disordered positions. Such disorder was modelled by using different models (three for the fluorine atoms bonded to C9B and two for all the other cases). In addition, the independent monoglyme molecule that coordinates Pb1A is affected by the disorder, that was modelled introducing two positions for all the carbon atoms (with the exception of C3, see Fig. S1). All the disordered atoms were isotropically refined, while their occupancy factors were freely refined.

Geometrical calculations were performed by PARST9772 and molecular plots were produced by the Mercury program (v4.1.2)73 and Discovery Studio Visualizer 2019.74 Crystallographic data and refinement parameters are reported in Table 1.

Table 1 Crystallographic data and refinement parameters for Pb(hfa)2·monoglyme
Empirical formula Pb(hfa)2·monoglyme
Formula weight 711.425
Temperature (K) 100
Wavelength (Å) 0.71074
Crystal system, space group Triclinic, P[1 with combining macron]
Unit cell dimensions (Å, °) a = 11.768(2); α = 76.220(4)
b = 11.888(1); β = 74.385(4)
c = 15.829(2); γ = 85.943(5)
Volume (Å3) 2071.4(4)
Z, Dc (mg cm−3) 4, 2.281
μ (mm−1) 8.281
F(000) 668
θ range (°) 1.956–28.365
Reflections collected/unique 97[thin space (1/6-em)]686/10[thin space (1/6-em)]360
Data/parameters 10[thin space (1/6-em)]360/593
Goodness-of-fit on F2 1.017
Final R indices [I > 2σ(I)] R 1 = 0.0409, wR2 = 0.0812
R indices (all data) R 1 = 0.0695, wR2 = 0.0942


2.5 Synthesis of CsPbBr3 microcrystals

The synthesis of the perovskite microcrystals took place through a precipitation reaction conducted by using the method illustrated in ref. 75, where [Pb(hfa)2·diglyme]2 was used as lead source. The cesium precursor was synthesized through the procedure reported in ref. 76.

The precipitation reaction took place in an ethanol solution (EtOH 87 mmol, 5.024 ml) containing Cs(hfa) (1 mmol, 0.340 g) and “Pb(hfa)2·glyme” (1 mmol) through the addition of liquid Br2 (1.5 mmol, 0.240 g). For the lead precursor, the following amounts were used for Pb(hfa)2·monoglyme (0.711 g), [Pb(hfa)2·diglyme]2 (0.755 g), Pb(hfa)2·triglyme·H2O (0.799 g) and Pb(hfa)2·tetraglyme (0.844 g). After precipitation, perovskite microcrystals were collected by filtration and dried overnight in air. A yield in the range 50–60% was found for the CsPbBr3 samples synthesized from [Pb(hfa)2·diglyme]2, Pb(hfa)2·triglyme·H2O and Pb(hfa)2·tetraglyme precursors, while a yield of around 40% was obtained for the sample produced from the Pb(hfa)2·monoglyme.

2.6 Characterization of CsPbBr3 microcrystals

Attenuated Total Reflection infrared spectra were recorded using a Spectrum Two FT-IR PerkinElmer spectrometer. XRD patterns were recorded in the Bragg–Brentano mode using a Smartlab Rigaku diffractometer equipped with a rotating Cu Kα anode operating at 45 kV and 200 mA. During the acquisition, a 0.02° increment step was used. A ZEISS Supra 55VP field-emission scanning electron microscope was used to carry out the morphological characterization using an electron beam energy of 15 keV. Samples of as-synthesized CsPbBr3 microcrystals were attached to Al stubs using graphite double-sided adhesives in order to characterise the morphological features. The atomic composition of the powders was determined using energy dispersive X-ray (EDX) analysis by means of an INCA-Oxford “windowless” detector with a resolution of 127 eV, determined as the full width half maximum (FWHM) of the Mn Kα. The UV–vis spectra of the samples were collected utilizing an Agilent Cary 60 UV–vis spectrophotometer, using a dispersion of 2 mg of CsPbBr3 microcrystals in 2 mL of ethanol.

3. Results and discussion

Novel lead complexes have been synthesized, in a single-step reaction, from the lead oxide, hexafluoroacetylacetone, and glyme ligands in dichloromethane. Each mixture has been refluxed under stirring for 2 hours through the following general equation:
PbO + 2Hhfa + glyme → “Pb(hfa)2·glyme” + H2O

1 Pb(hfa)2·monoglyme

2 [Pb(hfa)2·diglyme]2

3 Pb(hfa)2·triglyme·H2O

4 Pb(hfa)2·tetraglyme

After the solvent evaporation, precursors 1, 2 and 4 were obtained as light-yellow crystals. Compound 3 had a yellow sticky crystal-like consistency.

3.1 Single crystal structure of Pb(hfa)2·monoglyme

Various attempts have been done to grow single crystals of 1, 3 and 4, but unfortunately only the single crystal of 1 was of good quality, with all the other single crystals twinned.

In the asymmetric unit of Pb(hfa)2·monoglyme, two independent Pb(II) complexes are present. In both units, the Pb(II) atom is hexa-coordinated, the donor atoms being the oxygen atoms of two hfa anions and those of a monoglyme molecule. In Fig. 1 an ORTEP view of the asymmetric unit of Pb(hfa)2·monoglyme is reported.


image file: d3dt03989g-f1.tif
Fig. 1 Ortep-3 view of the asymmetric unit of Pb(hfa)2·monoglyme (ellipsoid probability: 50%). Only the most populated models for the disordered moieties have been reported. For the sake of clarity hydrogen atoms have been omitted.

The asymmetric disposition of the donor atoms around the metal cation may be related to the presence of the stereochemically active electron pair of Pb(II). As reported by Shimoni-Livay et al.,77 while in high coordination number (9 and 10) Pb(II) complexes the disposition of the ligands around the metal cation is holodirected (i.e. the directional effect of the lone pair is less evident) and in low coordination number (2–5) complexes hemidirected geometries are usually found (for example showing Pb-donor bonds situated in a part of the sphere), in intermediate coordination number (6–8) lead complexes there can be active or inactive lone pairs. In the present case, both the fundamental geometrical features that indicated the presence of a stereochemically active electron pair (i.e. 1: a gap of coordination in the region where the lone pair was thought to be located and 2: a shortening of the distance between Pb and the donor atom located in the opposite side of a Pb(II) cation relative to the proposed site of the lone pair, in this case O1A and O1B) were observed.56 The two independent Pb(hfa)2·monoglyme complexes were quite well superimposable (see Fig. S2) and the Pb-donor distances were in agreement with those observed in the Cambridge Structural Database (CSD)78 for Pb/acac derivatives and Pb/ether complexes (see Table S1).79 Both the two independent complexes were involved in weak Pb⋯O interaction with a symmetry related complex (symmetry operation: −x, −y, 1 − z and 1 − x, 1 − y, −z for the Pb1A and Pb1B complexes, respectively) giving rise to the formation of dimers (see Fig. 2). Finally, no significant interactions between dimers were present in the crystal packing.


image file: d3dt03989g-f2.tif
Fig. 2 Pb1A complex (left) and Pb1B complex (right) dimers in Pb(hfa)2·monoglyme.

3.2 FT-IR characterization

All the “Pb(hfa)2·glyme” precursors have been characterized by Fourier transform (FT)-IR spectroscopy in the 4000–400 cm−1 range. All the spectra have been recorded as nujol mulls.

As shown in Fig. 3a, the spectra of precursors 1, 2 and 4 do not present any bands at 3600–3500 cm−1 related to the stretching of O–H. This aspect is indicative of the absence of water molecules coordinated to the metal ion for these adducts.


image file: d3dt03989g-f3.tif
Fig. 3 (a) FT-IR spectra of 1, 2, 3 and 4 as nujol mulls in the 4000–400 cm−1 range. (b) Comparison of the FT-IR spectra of 1, 2, 3 and 4 with the free Hhfa ligand in the 1400–1800 cm−1 region.

Adduct 3 presents, instead, a broad band at around 3500 cm−1 due to the presence of coordinated H2O molecules.

Fig. 3b shows an enlargement of the FT-IR spectra of adducts 1, 2, 3 and 4 overlapped with the free H-hfa ligand spectrum. For the free ligand two peaks are observed at 1690 cm−1, due to the C[double bond, length as m-dash]O stretching, and at 1630 cm−1, caused by the C[double bond, length as m-dash]C stretching. For adducts 2, 3 and 4 it can be observed that the peak related to C[double bond, length as m-dash]O is slightly shifted at around 1675 cm−1, while for adduct 1 it is possible to observe the peak at around 1650 cm−1. This is indicative of hfa coordination to lead ion.

3.3 NMR characterization

The NMR spectra of “Pb(hfa)2·glyme” complexes 1–4 have been recorded in CD3CN; the complete signal attribution is reported in Table 2. The spectra clearly show the signal of both the polyether moieties and the hfa anions, as previously reported for similar complexes;61,64 neither the 1H nor the 13C spectra show evidence of tautomeric equilibria for the hfa moieties: the anionic enolate form is the only species observed in a solution for all the adducts.
Table 2 NMR data for the “Pb(hfa)glyme” complexes 1–4
  1H NMR 13C NMR
Complex CO–CH[double bond, length as m-dash]C–O Polyethera CO–CH[double bond, length as m-dash]C–O CO–CH[double bond, length as m-dash]C–O CF3 Polyethera
a The notations used for the polyether moieties :are monoglyme (CH3a–O–CH2b)2, diglyme (CH3a–O–CH2bCH2c)2–O, triglyme (CH3a–O–CH2b–CH2c–O–CH2d–)2, and tetraglyme (CH3a–O–CH2b–CH2c–O–CH2d–CH2e)2–O.
1 5.90 (s, 2H) a: 3.35 (s, 6H) 90.63 175.23 (q, 2JCF = 33.7 Hz) 118.17 (q, 1JCF = 284.1 Hz) a: 57.93
b: 3.53 (4H) b: 71.41
2 5.88 (s, 2H) a: 3.40 (s, 6H) 90.05 175.04 (q, 2JCF = 33.2 Hz) 118.21 (q, 1JCF = 287.4 Hz) a: 58.10
b: 3.62 (m, 4H) b: 69.78
c: 3.70 (m, 4 H) c: 71.24
3 5.87 (s, 2H) a: 3.40 (s, 6H) 89.67 174.88 (q, 2JCF = 32.9 Hz) 118.24 (q, 1JCF = 291.78 Hz) a: 58.16
b: 3.63 (m, 4H) b: 69.36
c, d: 3.74 (m, 8H) c: 69.70
d: 71.02
4 5.81 (s, 2H) a: 3.38 (s, 6H) 88.97 174.50 (q, 2JCF = 32.9 Hz) 118.29 (q, 1JCF = 288.5 Hz) a: 57.95
b: 3.59 (m, 4H) b: 69.09
c: 3.70 (m, 4H) c: 69.24
d, e: 3.74 (m, 8H) d: 69.58
e: 70.91


In the 1H-NMR spectra of the complexes (Table 2 and Fig. S3), the polyether chains account for: (i) a singlet at 3.3–3.4 ppm, consistent with the terminal methyl groups, and (ii) the singlets/multiplets at slightly lower fields (3.5–3.7 ppm) for the inner methylenic protons. In all the complexes the proton of the hfa anion resonates as a singlet at lower fields, namely 5.8–5.9 ppm, and this is a clear indication of the deprotonation of the hfa ligand. Moreover, the integration values observed for adducts 1, 2, 3, and 4 (reported in Table 2) confirm the expected stoichiometries and those defined by the X-ray diffraction analysis for 1 and 2.

In the 13C NMR spectra (Table 2, and Fig. S4) we observe the signals of the hfa anions: the CH group resonates at 89–91 ppm, while the CF3 and CO groups resonate as quartets (Fig. S5), due to the coupling of 13C with 19F nuclei, at lower fields ≈118 ppm and ≈175 ppm, respectively, with coupling constants of 284–290 Hz for 1JCF and 32–33 Hz for 2JCF. The coordinated polyethers exhibit signals at 58 ppm for the terminal methyl groups, and at 69–71 ppm for the inner methylene carbons.

3.4 Thermal analysis

The thermal behaviour of the lead precursors has been investigated though thermogravimetric (TG) analysis (Fig. 4), differential scanning calorimetry (DSC) (Fig. 5), and the Kofler measurement of the melting points (values in the inset of Fig. 5).
image file: d3dt03989g-f4.tif
Fig. 4 TG and DTG profiles of 1, 2, 3 and 4 under N2 flow and atmospheric pressure in the temperature range 25–400 °C.

image file: d3dt03989g-f5.tif
Fig. 5 DSC profiles of 1, 2, 3 and 4 under N2 flow and atmospheric pressure in the temperature range 25–400 °C and melting points of the adducts through DSC curves and Kofler measurements.

TG curves (Fig. 4) of all the adducts show a single-step mass loss related to their vaporisation. In particular, at 350 °C, adducts 1, 2 and 4 show a residue of about 7.4%, 5.1% and 5.9%, respectively. While at the same temperature, the TG curve of adduct 3 displays a higher residue of 14.3%.

Furthermore, for adduct 3, we have carried out an energy dispersive X-ray analysis (EDX) of the residue of the TGA measurements in order to obtain information about the residue's nature and investigate the vaporization process. The spectrum, as shown in Fig. S6, shows the presence of Pb and F peaks as main elements, while the presence of the carbon peak is likely related to the carbon tape used as support for the powder analysis.

Consequently, from the TG analyses it is evident that adducts 1, 2, and 4 present very low residues and a good thermal behaviour and thus these compounds are likely suitable not only in solution synthetic processes, taking advantage of their high solubility in common organic solvents, but also as precursors for vapor-phase methods.

To further investigate the thermal behaviour of the adducts, DSC characterization has been carried out and reported in Fig. 5. All the curves show endothermic peaks in the temperature range between 56 °C and 116 °C. These peaks may be related to the adduct melting processes. Notably, at higher temperature, in the range of 246–276 °C it is possible to observe for each complex the presence of exothermic peaks that can be likely associated with a partial decomposition overlapped with the incipient vaporization of the precursors.

Specifically, the DSC curves show endothermic peaks, associated with melting of the adducts, at 57 °C (1), 81 °C (2), 71 °C (3), and 117 °C (4).

All the information about the melting of the adducts obtained from the DSC curves are compared with the melting points obtained through a Kofler hot-stage microscope analyses, whose data are reported in the Fig. 5 inset table.

3.5 Synthesis, characterisation, and stability of CsPbBr3 microcrystals

The four adducts have been applied for the synthesis of the CsPbBr3 microcrystals through solubilization in ethanol together with the Cs(hfa) precursor and bromine. The samples are indicated as: CsPbBr3_1 for the sample obtained from Pb(hfa)2·monoglyme, CsPbBr3_2 for the sample obtained from [Pb(hfa)2·diglyme]2, CsPbBr3_3 for the sample obtained from Pb(hfa)2·triglyme·H2O, and CsPbBr3_4 for the sample obtained from Pb(hfa)2·tetraglyme. All the samples are seen by the naked eye as an intense orange colour. Some differences are observed in relation to the yield of the four samples; in particular the CsPbBr3_1 sample derived from the monoglyme adduct is produced in lower yield, about 40%, with respect to an average of 50–60% for the samples obtained from the other precursors.

The structural characterization of the as-prepared microcrystals CsPbBr3_1, CsPbBr3_2, CsPbBr3_3 and CsPbBr3_4 are shown in Fig. 6. The XRD patterns exhibit the formation of a pure CsPbBr3 perovskite phase for all the four samples as confirmed by comparison with the diffraction file ICDD 18-0364. Therefore, all these precursors show good behaviour and suited reactivity in solutions to be applied to produce CsPbBr3 through a simple precipitation method. Then, to investigate the stability of the as-prepared CsPbBr3 samples, the microcrystals have been subjected to XRD characterization after 6 months of storage in air under atmospheric pressure.


image file: d3dt03989g-f6.tif
Fig. 6 XRD patterns of CsPbBr3 microcrystals synthesized from Cs(hfa) and the “Pb(hfa)2·glyme” precursor: (a) CsPbBr3_1, (b) CsPbBr3_2, (c) CsPbBr3_3, and (d) CsPbBr3_4. The continuous lines represent the as-prepared samples and the dotted lines represent the six-month aged samples. The orange lines represent the theoretical pattern of the CsPbBr3 phase (ICDD n. 18-0364) and the blue ones are related to Cs4PbBr6 (ICDD n. 73-2478).

Notably, the XRD patterns of the six-month aged CsPbBr3 powders, obtained from adducts 1, 2 and 4, do not exhibit relevant changes with respect to the initial patterns, as shown in Fig. 6a, b and d, respectively, where the dotted line patterns represent the pattern of the aged samples. The peak positions and the intensities remain unchanged, suggesting the preservation of the perovskite structure and crystalline integrity. It is worth noting a different behaviour for the XRD pattern of CsPbBr3_3 after six-month storage (Fig. 6c, dotted line). In this case, we found traces of impurities associated with the Cs4PbBr6 phase,80–82 as confirmed by comparison with the diffraction file ICDD 73-2478.

To obtain some hints on the different stability behavior of the four samples, FT-IR and TGA studies have been carried out on the four freshly synthesized CsPbBr3 microcrystals in order to investigate the presence of ligands on the perovskite particle surface. The IR spectra of all the CsPbBr3 samples have been recorded in the ATR mode to avoid any interference of the nujol or KBr matrix. Extremely small peaks are visible only in the y-axis enlarged graphic reported in the inset of Fig. S7. As shown in the figure inset, the spectra of CsPbBr3_1, CsPbBr3_2, CsPbBr3_3 and CsPbBr3_4 have small peaks at around 1650, 1200 and 1100 cm−1, associable with hfa ligand vibrational modes, thus indicating the possibility of a small amount of the hfa ligand coordinated to the perovskite samples. The CsPbBr3_3 sample also shows additional peaks at around 3450 and 2900 cm−1. The peak at 3450 cm−1 is due to the O–H stretching mode, while the peak at 2900 cm−1 is likely due to the triglyme C–H stretching. The presence of these peaks indicates that very small traces of both ligands are present on the particle surface of the CsPbBr3_3 sample. TGA measurements confirm these hypotheses. In fact, a small weight loss in the range 5–7% is observed from 100 °C to 450 °C (Fig. S8), which could be associated with the loss of adsorbed ligands. These findings may justify the different stability of the CsPbBr3 samples derived from the four adducts, with the presence of a small amount of “H2O” and triglyme likely affecting the instability after aging of the CsPbBr3_3 sample.

The morphological characterization of the as-prepared samples has been conducted through FE-SEM analysis and reported in Fig. 7. Fig. 7a, b and d, related to the microcrystals obtained from precursors 1, 2 and 4, respectively, show good uniformity in shape with mainly cubic grains. In particular, for the CsPbBr3_1 sample the grain dimensions are mainly picked at around 3 μm (inset in Fig. 7a). In the inset of Fig. 7b, the grains of the CsPbBr3_2 sample have a size of about 1–1.5 μm. Fig. 7c, instead, shows the FE-SEM image of the CsPbBr3_3 microcrystals. In this case the crystals are less regular in both dimensions and shape than those observed in the other samples, and crystal size dimensions are in the range 1–2.5 μm (inset Fig. 7c). This trend can be likely rationalized considering the different reactivity of adduct 3 in the solution process may be due to the hydrated nature of the precursor, which leads to an inhomogeneity of the crystal precipitation process. Finally, a histogram of the sample CsPbBr3_4 (inset Fig. 7d) indicates an average dimension of the crystals of about 2 μm.


image file: d3dt03989g-f7.tif
Fig. 7 FE-SEM images of CsPbBr3 microcrystals synthesized from Cs(hfa) and the Pb(hfa)2·glyme precursor: (a) CsPbBr3_1, (b) CsPbBr3_2, (c) CsPbBr3_3, and (d) CsPbBr3_4.

The composition of the CsPbBr3 microcrystals has been determined through energy dispersive X-ray (EDX) analyses carried out on single grains. For each sample, several point-analyses have been collected in order to evaluate the homogeneity of the sample and confirm the correct stoichiometry of the CsPbBr3 phase. For the microcrystals obtained from precursors 1, 2, 3 and 4, the Cs[thin space (1/6-em)]:[thin space (1/6-em)]Pb[thin space (1/6-em)]:[thin space (1/6-em)]Br ratio is about 1[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]3, thus confirming the presence of the CsPbBr3 perovskite phase (Fig. S9–S12). Notably, in all the samples no peaks related to carbon (0.27 keV) or fluorine (0.67 keV), which could originate from the Cs(hfa) and “Pb(hfa)2·glyme” precursors, are found. These results confirm a clean decomposition process of the precursors without any by-products, yielding the formation of bromide perovskite phases.

Finally, the precursors shown in this work may be applied to prepare CsPbBr3 films. In fact, we recently reported for the [Pb(hfa)2·diglyme]2 precursor, that through the spray-coating of a solution containing the prepared microcrystals it is possible to deposit a thin film of CsPbBr3.83

3.6 Optical properties of CsPbBr3 microcrystals

To investigate the optical properties of the perovskite microcrystals, UV–vis analyses of the microcrystals dispersed in ethanol have been carried out. The absorbance spectra in the UV–vis range of the CsPbBr3 powders obtained from the new Pb adducts have been used to derive the optical band-gap of the material. The optical band-gap energy (Eg) of the powders has been calculated from the absorption spectrum through the Tauc equation:84
image file: d3dt03989g-t1.tif
where h is the Planck constant, ν is the frequency of the photon, Eg is the optical band gap energy, and B is a constant. The γ factor depends on the type of the electronic transition and is equal to ½ or 2 for the direct and indirect transition band gaps, respectively.

The UV–vis spectra of the CsPbBr3 dispersion in ethanol are reported in Fig. 8, while Tauc plots, obtained from the relation of (αhν)2versus () calculated from the optical measurement, are reported as insets in the respective UV–vis spectrum graphs.


image file: d3dt03989g-f8.tif
Fig. 8 UV–vis spectra of CsPbBr3 microcrystals dispersed in ethanol synthesized from Cs(hfa) and the “Pb(hfa)2·glyme” precursor: (a) CsPbBr3_1, (b) CsPbBr3_2, (c) CsPbBr3_3, and (d) CsPbBr3_4. In the inset, Tauc plot (αhν)2 against photon energy () of the CsPbBr3 powders. The dotted lines represent the linear extrapolation of the Eg value.

All the UV–vis spectra show a sharp absorbance ranging from 518 to 523 nm for the perovskite dispersion. Furthermore, the linear extrapolations from the Tauc's plots provide the following values for the direct optical band-gaps: 2.21 eV for CsPbBr3_1, 2.23 eV for CsPbBr3_2, 2.27 eV CsPbBr3_3 and 2.26 eV for CsPbBr3_4.

The values of the absorption peak17,81,85 and the optical band-gap values are in good agreement with literature data obtained under similar conditions.86 Additionally, the Eg values are suitable for photon absorption in the visible region, making these microcrystals useful in a variety of optical applications.

4. Conclusions

In this study, novel lead complexes of the type “Pb(hfa)2·glyme” were successfully synthesized using a single-step reaction involving lead oxide, hexafluoroacetylacetone and glyme ligands. Thermal analyses have demonstrated a good stability of these lead adducts, making them suitable for various applications, ranging from vapor to solution processes.

As a proof-of-concept, these lead complexes have been successfully applied as precursors, together with Cs(hfa) and Br2, which were used as cesium and bromine sources, respectively, in a green solution synthesis of CsPbBr3 microcrystals. The X-ray diffraction measurements confirmed the formation of the pure perovskite CsPbBr3 structure from all the four Pb precursors. It is worth noting the excellent stability of the perovskite CsPbBr3 microcrystals even after six months of storage under ambient conditions.

Among the four adducts, Pb(hfa)2·monoglyme and [Pb(hfa)2·triglyme·H2O] are the less promising adducts for the synthesis of the CsPbBr3 microcrystals. In particular, Pb(hfa)2·monoglyme produced the CsPbBr3 microcrystals in a lower yield. On the other hand, [Pb(hfa)2·triglyme·H2O] is less promising for different reasons: (i) a less homogeneous distribution of the CsPbBr3_3 crystal dimensions; and (ii) minor stability of the CsPbBr3_3 sample after six-month storage with respect to the other synthesized CsPbBr3 samples. This finding may be related to the presence of H2O in the coordination sphere, which is likely responsible for the presence of hydroxyl groups on the microcrystal surface. The good optical properties of this type of system are confirmed by UV–vis spectrophotometric analysis measurements, enabling a variety of applications, such as energy conversion and photocatalysis.

The present green solution synthesis shows numerous benefits including the absence of unsafe organic solvents and the mild working environment (room temperature and atmospheric pressure).

Finally, one of the biggest advantages of our approach is the possibility to deposit the perovskite film on highly thermally sensitive substrates such as PET or silicon solar cells. Our proof-of-concept paves the way for the use of our precursors for the preparation of flexible optoelectronic devices or silicon/perovskite tandem solar cells.

Author contributions

Lorenzo Sirna: investigation, formal analysis and writing – original draft. Anna Lucia Pellegrino: validation, data curation, writing – review & editing. Salvatore Sciacca: investigation and data curation. Martina Lippi: investigation and data curation. Patrizia Rossi: methodology and validation. Carmela Bonaccorso: investigation and data curation. Giuseppe Bengasi: visualization and methodology. Marina Foti: visualization and methodology. Graziella Malandrino: supervision, funding acquisition and writing – review & editing.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This research was funded by the University of Catania within the PIACERI research program UNICT 2020-22 Linea 2- project MatT-onE. A. L. P. and L. S. thank the Ministero dell'Università e della Ricerca within the PON “Ricerca e Innovazione” 2014-2020 Azioni IV.4 program. C. B. acknowledges the University of Catania for the funding received under the “PIAno di inCEntivi per la Ricerca di Ateneo 2020/2022 Pia.Ce.Ri. - Linea di intervento 3 Starting Grant - Project SiFiChrom. The authors thank Bionanotech Research and Innovation Tower (BRIT) laboratory of the University of Catania (Grant no. PONa3_00136 financed by the Italian Ministry for Education, University and Research, MIUR) for the diffractometer facility. Open access funding was provided by Università degli Studi di Catania.

References

  1. A. Kojima, K. Teshima, Y. Shirai and T. Miyasaka, J. Am. Chem. Soc., 2009, 131, 6050–6051 CrossRef CAS PubMed.
  2. W. J. Nimens, J. Ogle, A. Caruso, M. Jonely, C. Simon, D. Smilgies, R. Noriega, M. Scarpulla and L. Whittaker-Brooks, ACS Appl. Energy Mater., 2018, 1, 602–615 CrossRef CAS.
  3. Y. Dou, S. Wang, C. Zhang, H. Luo, X. Li, H. Wang, F. Cao, P. Shen, J. Zhang and X. Yang, Adv. Mater. Technol., 2020, 5, 1901089 CrossRef CAS.
  4. E. Akman, T. Ozturk, W. Xiang, F. Sadegh, D. Prochowicz, M. M. Tavakoli, P. Yadav, M. Yilmaz and S. Akin, Energy Environ. Sci., 2023, 16, 372–403 RSC.
  5. C. Wehrenfennig, G. E. Eperon, M. B. Johnston, H. J. Snaith and L. M. Herz, Adv. Mater., 2014, 26, 1584–1589 CrossRef CAS PubMed.
  6. H. Huang, M. I. Bodnarchuk, S. v. Kershaw, M. v. Kovalenko and A. L. Rogach, ACS Energy Lett., 2017, 2, 2071–2083 CrossRef CAS PubMed.
  7. A. K. Jena, A. Kulkarni and T. Miyasaka, Chem. Rev., 2019, 119, 3036–3103 CrossRef CAS PubMed.
  8. Y. Lei, Y. Chen, R. Zhang, Y. Li, Q. Yan, S. Lee, Y. Yu, H. Tsai, W. Choi, K. Wang, Y. Luo, Y. Gu, X. Zheng, C. Wang, C. Wang, H. Hu, Y. Li, B. Qi, M. Lin, Z. Zhang, S. A. Dayeh, M. Pharr, D. P. Fenning, Y. H. Lo, J. Luo, K. Yang, J. Yoo, W. Nie and S. Xu, Nature, 2020, 583, 790–795 CrossRef CAS PubMed.
  9. J. P. Correa-Baena, A. Abate, M. Saliba, W. Tress, T. Jesper Jacobsson, M. Grätzel and A. Hagfeldt, Energy Environ. Sci., 2017, 10, 710–727 RSC.
  10. X. Li, F. Cao, D. Yu, J. Chen, Z. Sun, Y. Shen, Y. Zhu, L. Wang, Y. Wei, Y. Wu and H. Zeng, Small, 2017, 13, 1603996 CrossRef PubMed.
  11. Z. Guo, Y. Wan, M. Yang, J. Snaider, K. Zhu and L. Huang, Science, 2017, 356, 59–62 CrossRef CAS PubMed.
  12. L. Rao, Y. Tang, C. Song, K. Xu, E. T. Vickers, S. Bonabi Naghadeh, X. Ding, Z. Li and J. Z. Zhang, Chem. Mater., 2019, 31, 365–375 CrossRef CAS.
  13. Z. Li, C. Song, J. Li, G. Liang, L. Rao, S. Yu, X. Ding, Y. Tang, B. Yu, J. Ou, U. Lemmer and G. Gomard, Adv. Mater. Technol., 2020, 5, 1900941 CrossRef CAS.
  14. N. Pellet, J. Teuscher, J. Maier and M. Grätzel, Chem. Mater., 2015, 27, 2181–2188 CrossRef CAS.
  15. L. Rao, X. Ding, X. Du, G. Liang, Y. Tang, K. Tang and J. Z. Zhang, Beilstein J. Nanotechnol., 2019, 10, 666–676 CrossRef CAS PubMed.
  16. H. Dong, C. Ran, W. Gao, M. Li, Y. Xia and W. Huang, eLight, 2023, 3, 1 CrossRef PubMed.
  17. L. Protesescu, S. Yakunin, M. I. Bodnarchuk, F. Krieg, R. Caputo, C. H. Hendon, R. X. Yang, A. Walsh and M. v. Kovalenko, Nano Lett., 2015, 15, 3692–3696 CrossRef CAS PubMed.
  18. Y. Ren, J. Hua, Z. Han, M. Sun and S. Lü, Chem. Eng. J., 2023, 452, 139160 CrossRef CAS.
  19. Y. Tong, X. Bi, S. Xu, H. Min, L. Cheng, Z. Kuang, L. Yuan, F. Zhou, Y. Chu, L. Xu, L. Zhu, N. Zhao, N. Wang, W. Huang and J. Wang, Adv. Mater., 2023, 35, 2207111 CrossRef CAS PubMed.
  20. L. Rao, B. Sun, Y. Liu, G. Zhong, M. Wen, J. Zhang, T. Fu, S. Wang, F. Wang and X. Niu, Nanomaterials, 2023, 13, 355 CrossRef CAS PubMed.
  21. X. Li, C. Liu, F. Ding, Z. Lu, P. Gao, Z. Huang, W. Dang, L. Zhang, X. Lin, S. Ding, B. Li, Y. Huangfu, X. Shen, B. Li, X. Zou, Y. Liu, L. Liao, Y. Wang and X. Duan, Adv. Funct. Mater., 2023, 2213360 CrossRef CAS.
  22. W. Tian, H. Zhou and L. Li, Small, 2017, 13, 1702107 CrossRef PubMed.
  23. M. M. Stylianakis, T. Maksudov, A. Panagiotopoulos, G. Kakavelakis and K. Petridis, Materials, 2019, 12, 859 CrossRef CAS PubMed.
  24. P. Liu, B. Yu, W. Cai, X. Yao, K. Chang, X. Zhao, Z. Si, W. Deng, Y. Zhou, G. Zhou and G. Wei, J. Mater. Chem. C, 2023, 11, 2282 RSC.
  25. Z. Y. Chen, N. Y. Huang and Q. Xu, Coord. Chem. Rev., 2023, 481, 215031 CrossRef CAS.
  26. S. Saris, A. Loiudice, M. Mensi and R. Buonsanti, J. Phys. Chem. Lett., 2019, 10, 7797–7780 CrossRef CAS PubMed.
  27. H. Zhang, M. K. Nazeeruddin and W. C. H. Choy, Adv. Mater., 2019, 31, 1805702 CrossRef PubMed.
  28. N. N. Lal, Y. Dkhissi, W. Li, Q. Hou, Y. B. Cheng and U. Bach, Adv. Energy Mater., 2017, 7, 1602761 CrossRef.
  29. X. Liu, J. Li, X. Cui, X. Wang and D. Yang, J. Mater. Chem. C, 2023, 11, 426–455 RSC.
  30. R. Montecucco, E. Quadrivi, R. Po and G. Grancini, Adv. Energy Mater., 2021, 11, 2100672 CrossRef CAS.
  31. C. Kang, S. Xu, H. Rao, Z. Pan and X. Zhong, ACS Energy Lett., 2023, 8, 909–916 CrossRef CAS.
  32. H. Mei, Y. Zhai, Q. Q. Zhu, N. Wu, H. Zhang, P. Liang and L. Wang, Phys. Chem. Chem. Phys., 2023, 25, 1279–1289 RSC.
  33. C. Y. Huang, H. Li, Y. Wu, C. H. Lin, X. Guan, L. Hu, J. Kim, X. Zhu, H. Zeng and T. Wu, Nano-Micro Lett., 2023, 15, 16 CrossRef CAS PubMed.
  34. K. Huang, J. Liu, J. Yuan, W. Zhao, K. Zhao and Z. Zhou, J. Mater. Chem. A, 2023, 11, 4487–4509 RSC.
  35. S. Öz, A. K. Jena, A. Kulkarni, K. Mouri, T. Yokoyama, I. Takei, F. Ünlü, S. Mathur and T. Miyasaka, ACS Energy Lett., 2020, 5, 1292–1299 CrossRef.
  36. Y. Zhao and K. Zhu, Chem. Soc. Rev., 2016, 45, 655–689 RSC.
  37. S. Kumar, M. Regue, M. A. Isaacs, E. Freeman and S. Eslava, ACS Appl. Energy Mater., 2020, 3, 4509–4522 CrossRef CAS.
  38. X. Zhu, Y. Lin, J. San Martin, Y. Sun, D. Zhu and Y. Yan, Nat. Commun., 2019, 10, 2843 CrossRef PubMed.
  39. Z. Chen, Y. Hu, J. Wang, Q. Shen, Y. Zhang, C. Ding, Y. Bai, G. Jiang, Z. Li and N. Gaponik, Chem. Mater., 2020, 32, 1517–1525 CrossRef CAS.
  40. J. Yu, G. Liu, C. Chen, Y. Li, M. Xu, T. Wang, G. Zhao and L. Zhang, J. Mater. Chem. C, 2020, 8, 6326–6341 RSC.
  41. E. Aznar-Gadea, I. Sanchez-Alarcon, A. Soosaimanickam, P. J. Rodriguez-Canto, F. Perez-Pla, J. P. Martínez-Pastor and R. Abargues, J. Mater. Chem. C, 2022, 10, 1754–1766 RSC.
  42. D. Zhang, S. W. Eaton, Y. Yu, L. Dou and P. Yang, J. Am. Chem. Soc., 2015, 137, 9230–9233 CrossRef CAS PubMed.
  43. S. Wei, Y. Yang, X. Kang, L. Wang, L. Huang and D. Pan, Chem. Commun., 2016, 52, 7265–7268 RSC.
  44. X. Liang, R. W. Baker, K. Wu, W. Deng, D. Ferdani, P. S. Kubiak, F. Marken, L. Torrente-Murciano and P. J. Cameron, React. Chem. Eng., 2018, 3, 640–644 RSC.
  45. D. Liu, C. Yang, M. Bates and R. R. Lunt, iScience, 2018, 6, 272–279 CrossRef CAS PubMed.
  46. J. Zhang, C. Li, Y. Liang, J. Song, Q. Shang, L. Zhao, H. Tian, L. Liu and Q. Zhang, Adv. Funct. Mater., 2023, 33, 2208841 CrossRef CAS.
  47. K. Sun, Z. Bao, X. Guo, J. Ou, Y. Lv, D. Zou, L. Song, Y. Li, X. Liu and J. Liang, J. Mater. Chem. C, 2022, 10, 9538–9545 RSC.
  48. Q. Huang, Y. Liu, F. Li, M. Liu and Y. Zhou, Mater. Today, 2021, 47, 156–169 CrossRef CAS.
  49. A. Ishteev, L. Luchnikov, D. S. Muratov, M. Voronova, A. Forde, T. Inerbaev, V. Vanyushin, D. Saranin, K. Yusupov, D. Kuznetsov and A. di Carlo, Appl. Phys. Lett., 2021, 11, 071901 CrossRef.
  50. M. Liu, M. B. Johnston and H. J. Snaith, Nature, 2013, 501, 395–398 CrossRef CAS PubMed.
  51. Q. Huang, F. Li, M. Wang, Y. Xiang, L. Ding and M. Liu, Sci. Bull., 2021, 66, 757–760 CrossRef CAS PubMed.
  52. Y. el Ajjouri, F. Palazon, M. Sessolo and H. J. Bolink, Chem. Mater., 2018, 30, 7423–7427 CrossRef CAS.
  53. R. D. Shannon, Acta Crystallogr., Sect. A: Cryst. Phys., Diffr., Theor. Gen. Crystallogr., 1976, 32, 751 CrossRef.
  54. M. Shimizu and T. Shiosaki, Mater. Res. Soc. Symp. Proc., 1995, 401, 129 CrossRef.
  55. M. Tong, G. Dai and D. Gao, Mater. Lett., 2000, 46, 60–64 CrossRef CAS.
  56. G. Malandrino, R. Lo Nigro, P. Rossi, P. Dapporto and I. L. Fragalà, Inorg. Chim. Acta, 2004, 357, 3927–3933 CrossRef CAS.
  57. S. Mishra and S. Daniele, Chem. Rev., 2015, 115, 8379–8448 CrossRef CAS PubMed.
  58. A. Devi, Coord. Chem. Rev., 2013, 257, 3332–3384 CrossRef CAS.
  59. P. A. Vigato, V. Peruzzo and S. Tamburini, Coord. Chem. Rev., 2009, 253, 1099–1201 CrossRef CAS.
  60. R. C. Mehrotra, Pure Appl. Chem., 1988, 60, 1349–1365 CrossRef CAS.
  61. N. Peddagopu, A. L. Pellegrino, C. Bonaccorso, P. Rossi, P. Paoli and G. Malandrino, Molecules, 2022, 27, 6282 CrossRef CAS PubMed.
  62. V. V. Krisyuk, I. A. Baidina and I. K. Igumenov, Main Group Met. Chem., 1998, 21, 4 Search PubMed.
  63. N. Peddagopu, S. Sanzaro, P. Rossi, P. Paoli and G. Malandrino, Eur. J. Inorg. Chem., 2021, 36, 3776–3780 CrossRef.
  64. N. Peddagopu, P. Rossi, C. Bonaccorso, A. Bartasyte, P. Paoli and G. Malandrino, Dalton Trans., 2020, 49, 1002–1006 RSC.
  65. M. E. Fragalà, R. G. Toro, P. Rossi, P. Dapporto and G. Malandrino, Chem. Mater., 2009, 21, 2062–2069 CrossRef.
  66. F. lo Presti, A. L. Pellegrino and G. Malandrino, Dalton Trans., 2022, 51, 7352 RSC.
  67. G. Malandrino and I. L. Fragalà, Coord. Chem. Rev., 2006, 250, 1605–1620 CrossRef CAS.
  68. Bruker, Bruker APEX2, Bruker AXS Inc., Madison, Wisconsin, USA, 2012 Search PubMed.
  69. Bruker, Bruker SAINT, Bruker AXS Inc., Madison, Wisconsin, USA, 2012 Search PubMed.
  70. M. C. Burla, R. Caliandro, M. Camalli, B. Carrozzini, G. L. Cascarano, L. De Caro, C. Giacovazzo, G. Polidori and R. Spagna, J. Appl. Crystallogr., 2005, 38, 381–388 CrossRef CAS.
  71. G. M. Sheldrick, Acta Crystallogr., Sect. C: Struct. Chem., 2015, 71, 3–8 Search PubMed.
  72. M. Nardelli, J. Appl. Crystallogr., 1995, 28, 659–659 CrossRef CAS.
  73. C. F. Macrae, I. J. Bruno, J. A. Chisholm, P. R. Edgington, P. McCabe, E. Pidcock, L. Rodriguez-Monge, R. Taylor, J. van de Streek and P. A. Wood, J. Appl. Crystallogr., 2008, 41, 466–470 CrossRef CAS.
  74. Dassault Systèmes BIOVIA, Discovery Visualizer, v19.1.0.18287, Dassault Systèmes, San Diego, 2019 Search PubMed.
  75. A. L. Pellegrino and G. Malandrino, ACS Appl. Energy Mater., 2021, 4, 9431–9439 CrossRef CAS.
  76. E. S. Vikulova, K. V. Zherikova, N. V. Kuratieva, N. B. Morozova and I. K. Igumenov, J. Coord. Chem., 2013, 66, 2235–2249 CrossRef CAS.
  77. L. Shimoni-Livny, J. P. Glusker and C. W. Bock, Inorg. Chem., 1998, 37, 1853–1867 CrossRef CAS.
  78. C. R. Groom, I. J. Bruno, M. P. Lightfoot and S. C. Ward, Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater., 2016, 72, 171–179 CrossRef CAS PubMed.
  79. Pb–Oacac = compounds retrieved in the CSD: 41; fragments: 89, Pb–O distance range: 2.265–2.732 Å, mean value: 2.468 Å; Pb–Oether = compounds retrieved in the CSD: 117; fragments: 379, Pb–O distance range: 2.506–3.130 Å, mean value: 2.749 Å.
  80. H. Lu, Y. Tang, L. Rao, Z. Li, X. Ding, C. Song and B. Yu, Nanotechnology, 2019, 30, 295603 CrossRef CAS PubMed.
  81. G. C. Adhikari, S. Thapa, H. Zhu, A. Grigoriev and P. Zhu, J. Phys. Chem. C, 2019, 123, 12023–12028 CrossRef CAS.
  82. Z. Bao, H. C. Wang, Z. F. Jiang, R. J. Chung and R. S. Liu, Inorg. Chem., 2018, 57, 13071–13074 CrossRef CAS PubMed.
  83. L. Sirna, A. L. Pellegrino, F. Lo Presti, F. Faini, G. Grancini, G. Bengasi, M. Foti and G. Malandrino, Appl. Surf. Sci., 2023, 622, 156916 CrossRef CAS.
  84. P. Makuła, M. Pacia and W. Macyk, J. Phys. Chem. Lett., 2018, 9, 6814–6817 CrossRef PubMed.
  85. L. Protesescu, S. Yakunin, O. Nazarenko, D. N. Dirin and M. V. Kovalenko, ACS Appl. Nano Mater., 2018, 1, 1300–1308 CrossRef CAS PubMed.
  86. A. Bhardwaj and A. K. Kushwaha, ECS J. Solid State Sci. Technol., 2022, 11, 036002 CrossRef.

Footnote

Electronic supplementary information (ESI) available: 1H and 13C NMR spectra; EDX spectra. CCDC 2304600 (1). For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d3dt03989g

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.